Skip to main content
OpenTrials
Completed

NCT Number: NCT00194090

Efficacy of Celecoxib vs Placebo to Prevent Pain in a Paced Walk

A paced 20-minute walk is a reproducible model for acute pain in knee osteoarthritis

Completed

Looking for future studies?

Notify Me

Key information

Age range

45 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

University Hospitals of Cleveland

Cleveland, Ohio, 44106, United States

About this study

This is a randomizd, placbo-controlled, crossover trial comparing a single dose of celecoxib to placebo measuring the time to onset of acute pain in a paced 20-minute walk.

40 subjects will be enrolled

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Knee osteoarthritis by ACR clinical criteria Pain of at least 40 mm by VAS at baseline

-

Exclusion criteria

Non-pregant, non-lactating Able to stop active arthritis medication for washout Cardiovascular risk factors Abnormal EKG -

Treatment and study plan

Celecoxib

Drug

Primary outcomes

  1. time to onset of severe pain

Secondary outcomes

  1. time to onset of moderate pain

Sponsors and collaborators

Lead sponsor

University Hospitals Cleveland Medical Center

Other

Collaborators

  • Pfizer

Registry information

Official study title

A Double-blind, Placebo-controlled, Crossover Pilot Study of the Efficacy of Celecoxib 200 mg qd in Relieving Pain and Walking Dysfunction in Osteoarthritis of the Knee

Important dates

Study start
2004
Primary completion
2005
Study completion
2005
First posted
Sep 19, 2005
Registry last updated
Aug 26, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.